AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Antigen Construct, Cytokine Combo Treats and Prevents Male Malignancies.(Brief Article)

Vaccine Weekly

| December 26, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 DEC 26 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - University of Iowa researchers have developed recombinant therapies that can treat and prevent prostate cancer tumors in mice.

According to a contingent of investigators at the Iowa City, Iowa university, "Prostatic malignancies in 95% of patients continue to express PSA, making this antigen a good candidate for targeted immunotherapy." Because the cells in the prostrate are significant producers of PSA, they are key targets for directed therapies such as that developed by Bennett D. Elzey and others at University of Iowa.

The first portion of the therapy, an adenovirus construct, expresses recombinant prostate-specific antigen (PSA) while the second part of the therapy consists of viruses encoded for several cytokines. Together, the two constructs reduced tumor size and inhibited the formation of new tumors upon cancer cell rechallenge in murine models of prostate cancer.

"Immunization of mice with recombinant PSA adenovirus type 5 (Ad5-PSA) induced PSA-specific cellular and humoral immunity that was protective against a subcutaneous challenge with RM11 prostate cancer cells expressing PSA (RM11psa), but not mock-transfected RM11 tumor cells (RM11neo)," Elzey and coworkers said. The growth of existing tumors was not affected by adenoviral transfer of PSA.

Mice vaccinated with a control vector did not develop a similar protective immune response against prostate cancer cells, research team members maintained.

"Antitumor activity was predominantly mediated by CD8[superscript]+ T lymphocytes," they pointed out.

...

Related articles from newspapers, magazines, journals, and more
Data on prostate cancer detailed by P. Kesarwani and co-authors.
Newspaper article from: Cancer Weekly July 28, 2009 700+ words
...pathogenesis of prostate cancer (PCa). Polymorphisms...inflammatory cytokine gene can influence...see also Prostate Cancer). The researchers...with other cytokine gene polymorphisms...a risk for prostate cancer but may be...
Cytokine gene therapy staunches murine melanoma.
Newspaper article from: Biotech Week April 14, 2004 700+ words
...NewsRx.com & NewsRx.net) -- Cytokine gene therapy staunches murine melanoma...very useful vector system for in vivo cytokine gene therapy for established murine B16BL6...for the development of appropriate cytokine gene therapy," said Y. Okada and colleagues...
Cytokine gene therapy may overcome common barriers to glioma immunotherapy.
Newspaper article from: Biotech Week December 29, 2004 700+ words
...com & NewsRx.net) -- Cytokine gene therapy may overcome common barriers...highlights the recent literature on cytokine gene therapy for brain tumors, and proposes the effective use of cytokine gene delivery both at the site of vaccines...
Cytokine gene mutations linked to high graft-versus-host disease risk.
Newspaper article from: Blood Weekly January 2, 2003 700+ words
...host reactions in stem cell graft recipients. "Certain cytokine gene polymorphisms may be associated with severe acute graft...ki.se. Key points reported in this study include: * Cytokine gene mutations can predispose stem cell graft recipients to graft...
Cytokine gene polymorphisms in multifactorial conditions.(Brief Article)(Book...
Magazine article from: SciTech Book News December 1, 2006 700+ words
9780849336195 Cytokine gene polymorphisms in multifactorial conditions. Ed. by Koen Vandenbroeck...sclerosis, diabetes, and psoriasis are among the diseases related to cytokine gene polymorphisms in multifactorial conditions. In this volume...
Tumor irradiation improves cytokine gene therapy targeting murine kidney cancer.
Newspaper article from: Drug Week February 20, 2004 700+ words
...com & NewsRx.net) -- Tumor irradiation improves cytokine gene therapy targeting murine kidney cancer. "To circumvent...Gene Therapy (Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Therapy...
Murine model used to study cytokine gene therapy.
Newspaper article from: Immunotherapy Weekly January 15, 2003 700+ words
...Chen and colleagues concluded: "The results suggest that cytokine gene therapy exerts an antitumor effect on small tumors and may...characterization of a rectal cancer model in mice: Application to cytokine gene therapy. Int J Colorectal Dis, 2002;17(6):388...
Murine model used to study cytokine gene therapy.(Brief Article)
Newspaper article from: Vaccine Weekly January 15, 2003 700+ words
...Chen and colleagues concluded: "The results suggest that cytokine gene therapy exerts an antitumor effect on small tumors and may...characterization of a rectal cancer model in mice: Application to cytokine gene therapy. Int J Colorectal Dis, 2002;17(6):388...
For more facts and information, see all results

Source: HighBeam Research, Antigen Construct, Cytokine Combo Treats and Prevents Male...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA